MENU
+Compare
BDTX
Stock ticker: NASDAQ
AS OF
Apr 1, 04:59 PM (EDT)
Price
$1.49
Change
-$0.06 (-3.87%)
Capitalization
87.54M

BDTX Black Diamond Therapeutics Forecast, Technical & Fundamental Analysis

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BDTX with price predictions
Mar 31, 2025

BDTX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BDTX turned positive on March 20, 2025. Looking at past instances where BDTX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BDTX's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BDTX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

BDTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BDTX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BDTX entered a downward trend on March 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.014) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BDTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BDTX is expected to report earnings to fall 117.11% to 4 cents per share on May 07

Black Diamond Therapeutics BDTX Stock Earnings Reports
Q1'25
Est.
$0.05
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.08
The last earnings report on March 06 showed earnings per share of -28 cents, beating the estimate of -34 cents. With 1.72M shares outstanding, the current market capitalization sits at 87.54M.
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVLHF0.110.02
+19.54%
Nevada Lithium Resources Inc.
AOTVF0.08N/A
N/A
Ascot Resources Ltd.
REPYY13.31-0.18
-1.33%
Repsol S.A.
BAYRY6.02-0.12
-2.01%
Bayer A.G.
TLPFY50.28-1.88
-3.60%
Teleperformance

BDTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ACIU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ACIU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-3.73%
ACIU - BDTX
54%
Loosely correlated
-5.56%
RLAY - BDTX
42%
Loosely correlated
-3.68%
ABOS - BDTX
41%
Loosely correlated
-7.56%
CRSP - BDTX
39%
Loosely correlated
-8.00%
CCCC - BDTX
39%
Loosely correlated
-8.57%
More